Friday , June 5 2020
Home / Audit and Guideline / USFDA WARNING LETTER / 2019 / USFDA Warning Letter for Lohxa LLC

USFDA Warning Letter for Lohxa LLC

Lohxa LLC MARCS-CMS 581785 —

For Warning Letter Click Here –  

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.

Image result for usfda warning letter

For more USFDA warning Letter Visit :http://pharmaguidances.com/shop/guideline/usfda-warning-letter/

About Pharmaceutical Guidanace

Mr. Shiv Kumar is the Author and founder of pharmaceutical guidance, he is a pharmaceutical Professional from India having more than 14 years of rich experience in pharmaceutical field. During his career, he work in quality assurance department with multinational company’s i.e Zydus Cadila Ltd, Unichem Laboratories Ltd, Indoco remedies Ltd, Panacea Biotec Ltd, Nectar life Science Ltd. During his experience, he face may regulatory Audit i.e. USFDA, MHRA, ANVISA, MCC, TGA, EU –GMP, WHO –Geneva, ISO 9001-2008 and many ROW Regularities Audit i.e.Uganda,Kenya, Tanzania, Zimbabwe. He is currently leading a regulatory pharmaceutical company as a head Quality. You can join him by Email, Facebook, Google+, Twitter and YouTube

Check Also

USFDA Warning Letter for Pharmalab Enterprises, Inc.

Pharmalab Enterprises, Inc. MARCS-CMS 588432 — December 10, 2019 For Warning Letter Click Here –   …